According to a new report Global Nephrostomy Devices Market, published by KBV Research, The Global Nephrostomy Devices Market size is expected to reach $1.5 billion by 2025, rising at a market growth of 8% CAGR during the forecast period. Urinary stones remain a major public health burden and are among the oldest and common afflictions of human beings. Many people worldwide are affected by urinary stone problems.
The Hospital market dominated the Global Nephrostomy Devices Market by End Use in 2018. A higher knowledge among physicians of the nephrostomy devices is pushing the market together with growing cases of kidney stone disease. As they offer more personalized services, ambulatory surgical centers (ASCs) are likely to witness the fastest CAGR of 9% from 2019 to 2025. Also, the segment is driven by better outcomes compared to hospitals and other healthcare environments.
The largest market share was recorded by North America in 2018. Due to favorable reimbursement policies, increased product awareness, the accessibility of highly skilled physicians and the involvement of well-established healthcare facilities in the region, it is expected to see significant growth in the future as well. The Asia Pacific market is projected to be the most lucrative region in terms of market growth as the region is witnessing a CAGR of 9.3% during (2019 - 2025). Additionally, The Europe market is expected to witness a CAGR of 7.6% during (2019 - 2025).
Due to the less-invasive nature of the product, the Guidewires segment is expected to hold maximum market share during the forecast period. The increasing elderly and urinary and bladder disorders are projected to raise the product demand and thus influence segment growth. The Sheath Dilators market is expected to witness a CAGR of 8.4% during (2019 - 2025). The Drainage Tubes market would grow with the highest CAGR of 8.5% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/nephrostomy-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
By Product
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
